CoChat

A review on critical appraisal and pathogenesis of polycystic ovarian syndrome

Open access
Hajam, Younis Ahmad, Rather, Hilal Ahmad, Neelam, Kumar, Rajesh, Basheer, Muddasir, Reshi, Mohd Salim · 2024 · Endocrine and Metabolic Science
Cited by 65

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Polycystic Ovarian Syndrome (PCOS) is a complex endocrine disorder affecting reproductive-aged women, characterized by clinical manifestations such as hyperandrogenism, menstrual irregularities, and polycystic ovaries. Despite its prevalence and impact on women's health, the pathogenesis of PCOS remains incompletely understood. This review provides a comprehensive critical appraisal of existing literature on PCOS pathogenesis, addressing knowledge gaps and highlighting its multifactorial nature. A systematic literature review identified relevant articles published up to the knowledge cutoff date in 2023, focusing on molecular, genetic, hormonal, and environmental factors contributing to PCOS pathogenesis. Electronic databases, including PubMed, MEDLINE, and Embase, were systematically searched using predefined terms. Eligible studies investigated molecular, genetic, hormonal, and environmental factors associated with PCOS pathogenesis. The critical appraisal revealed diverse studies enriching our understanding of PCOS. Molecular and genetic studies highlighted alterations in signaling pathways, hormonal dysregulation, and the role of insulin resistance. Environmental factors, including lifestyle and exposure to endocrine-disrupting chemicals, were implicated. Heterogeneity in study designs and methodologies underscored the need for standardized approaches to enhance comparability. This review synthesizes current evidence on PCOS critical appraisal and pathogenesis, emphasizing its multifaceted nature. Standardization of study designs and methodologies will facilitate future comparisons, enabling the development of targeted therapeutic interventions and personalized management strategies for women affected by PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.endmts.2024.100162

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 200

  1. Abbasian, 2020, Therapeutic efficacy of Trifolium pratense L. on letrozole induced polycystic ovary syndrome in rats, Plant Science Today, 7, 501, 10.14719/pst.2020.7.3.845 · DOI
  2. Abdulrahman, 2023, Crude extract of Ficus deltoidea Jack (FD) as a natural biological therapy, Exploration of Targeted Anti-tumor Therapy, 4, 57, 10.37349/etat.2023.00123 · doi:10.37349/etat.2023.00123
  3. Aggarwal, 2004, Suppression of the nuclear factor-kB activation pathway by spice-derived phytochemicals, Ann. N. Y. Acad. Sci., 1030, 434, 10.1196/annals.1329.054 · DOI · Paper page
  4. Alaee, 2020, Capacity of Mentha spicata (spearmint) extract in alleviating hormonal and folliculogenesis disturbances in polycystic ovarian syndrome rat model, World, 10, 451
  5. Alfirevic, 2012, Caesarean section versus vaginal delivery for preterm birth in singletons, Cochrane Database Syst. Rev., 6, 10.1002/14651858.CD000078.pub2 · DOI
  6. Aliabadi, 2017, Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats, Arch. Gynecol. Obstet., 296, 957, 10.1007/s00404-017-4509-3 · DOI
  7. Alibraheemi, 2021, Effect of curcumin on LH and FSH hormones of polycystic syndrome induced by letrozole in female rats, Latin Amer. J. Pharm, 40, 179
  8. Amini, 2018, The synergistic effect of curcumin and ziziphora extract due to their anti-inflammatory and antioxidant properties on ovarian tissue follicles, Journal of Pharmaceutical Research International, 24, 1, 10.9734/JPRI/2018/45124 · doi:10.9734/jpri/2018/45124
  9. Ammar, 2021, Amelioration of polycystic ovary syndrome-related disorders by supplementation of thymoquinone and metformin, Middle East Fertility Society Journal, 26, 1, 10.1186/s43043-021-00076-1 · DOI
  10. Avery, 2011, A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy, Clin. Pharmacol. Ther., 90, 701, 10.1038/clpt.2011.186 · DOI
  11. Azziz, 2016, Stein and Leventhal: 80 years on, Am. J. Obstet. Gynecol., 214, 247-e1, 10.1016/j.ajog.2015.12.013 · DOI
  12. Badawy, 2011, Treatment options for polycystic ovary syndrome, Int. J. Women’s Health, 3, 25, 10.2147/IJWH.S11304 · DOI · Paper page
  13. Bannigida, 2018, Insulin resistance and oxidative marker in women with PCOS, Arch. Physiol. Biochem., 126, 183, 10.1080/13813455.2018.1499120 · DOI
  14. Barber, 2006, Obesity and polycystic ovary syndrome, Clin. Endocrinol., 65, 137, 10.1111/j.1365-2265.2006.02587.x · DOI · Paper page
  15. Basheer, 2018, Protective role of seed extract of Tephrosia purpurea in letrozole induced polycystic ovary syndrome in wistar rats, Aust. J. Biol. Sci., 18, 458, 10.3923/jbs.2018.458.467 · DOI
  16. Baskind, 2016, Hypothalamic–pituitary, ovarian and adrenal contributions to polycystic ovary syndrome, Best Pract. Res. Clin. Obstet. Gynaecol., 37, 80, 10.1016/j.bpobgyn.2016.03.005 · DOI
  17. Bergner, 2016, Glycyrrhiza: licorice root and testosterone, Med Herb, 11, 11
  18. Bhuvaneshwari, 2015, Comparative study of Pergularia daemia and Citrullus colocynthis in polycystic ovarian syndrome induced albino Wistar rats, Int J Multidisc Res Dev, 2, 207
  19. Borzoei, 2018, Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome, Asia Pac. J. Clin. Nutr., 27, 556
  20. Brown, 2012, Hypothalamic kiss1 mrna and Kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS), Brain Res., 1467, 1, 10.1016/j.brainres.2012.05.049 · DOI
  21. Cai, 2012, Clinical treatment of polycystic ovary syndrome of combination use of Gui Zhi Fu Ling Wan and berberine, Henan J Surg, 18, 60
  22. Caldwell, 2017, Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome, Proc. Natl. Acad. Sci. U. S. A., 114, E3334, 10.1073/pnas.1616467114 · DOI · Paper page
  23. Cappelli, 2017, Natural molecules for the therapy of hyperandrogenism and metabolic disorders in PCOS, Eur. Rev. Med. Pharmacol. Sci., 21, 15
  24. Cassidy-Vu, 2016, Role of statin drugs for polycystic ovary syndrome, J Family Reprod Health, 10, 165
  25. Cernea, 2015, Prenatal testosterone treatment leads to changes in the morphology of kndy neurons, their inputs, and projections to gnrh cells in female sheep, Endocrinology, 156, 3277, 10.1210/en.2014-1609 · DOI · Paper page
  26. Chan, 2006, Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome—a randomized placebo-controlled trial, J. Soc. Gynecol. Investig., 13, 63, 10.1016/j.jsgi.2005.10.006 · DOI
  27. Chang, 2019, The duration of endocrine therapy and breast cancer patients’ survival: A nationwide population-based cohort study, Medicine, 98, 10.1097/MD.0000000000017746 · DOI
  28. Chaudhari, 2018, Gnrh dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile, Reprod. Biol. Endocrinol., 16, 37, 10.1186/s12958-018-0354-x · DOI · Paper page
  29. Chaudhary, 2021, The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis, Journal of Ovarian Research, 14, 1, 10.1186/s13048-021-00879-w · DOI
  30. Chen, 2014, Anti-inflammatory and immunomodulatory mechanism of tanshinone IIA for atherosclerosis, Evid. Based Complement. Alternat. Med., 26797
  31. Cheong, 2016, Metabolic and endocrine differences between dairy cows that do or do not ovulate first postpartum dominant follicles, Biol. Reprod., 94, 18, 10.1095/biolreprod.114.127076 · doi:10.1095/biolreprod.114.127076
  32. Chhabra, 2005, Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied e_ects in hyperandrogenemic adolescent girls, J. Clin. Endocrinol. Metab., 90, 2810, 10.1210/jc.2004-2359 · DOI · Paper page
  33. Chien, 2021, Effects of curcumin on glycemic control and lipid profile in polycystic ovary syndrome: systematic review with meta-analysis and trial sequential analysis, Nutrients, 13, 684, 10.3390/nu13020684 · DOI · Paper page
  34. Ciebiera, 2021, Nutrition in gynecological diseases: current perspectives, Nutrients, 13, 1178, 10.3390/nu13041178 · DOI · Paper page
  35. Clarkson, 2017, PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution, Gynecol. Endocrinol., 33, 665, 10.1080/09513590.2017.1342240 · DOI
  36. Condorelli, 2017, PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution, Gynecol. Endocrinol., 33, 665, 10.1080/09513590.2017.1342240 · DOI
  37. Csaki, 2008, Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro, Biochem. Pharmacol., 75, 677, 10.1016/j.bcp.2007.09.014 · DOI · Paper page
  38. D’Anglemont de Tassigny, 2007, Hypogonadotropic hypogonadism in mice lacking a functional kiss1 gene, Proc. Natl. Acad. Sci. U. S. A., 104, 10714, 10.1073/pnas.0704114104 · DOI · Paper page
  39. Dabadghao, 2019, Polycystic ovary syndrome in adolescents, Best Pract. Res. Clin. Endocrinol. Metab., 33, 10.1016/j.beem.2019.04.006 · DOI · Paper page
  40. Darabi, 2020, Therapeutic potentials of the natural plant flavonoid apigenin in polycystic ovary syndrome in rat model: via modulation of pro-inflammatory cytokines and antioxidant activity, Gynaecol. Endocrinol., 36, 582, 10.1080/09513590.2019.1706084 · DOI
  41. Dawane, 2017, Study the efficacy of herbal formulation Nisamalaki in animal model of polycystic ovarian disease syndrome, Anc. Sci. Life, 37, 86, 10.4103/asl.ASL_51_18 · DOI
  42. DeFazio, 2002, Activation of a-type -aminobutyric acid receptors excites gonadotropin-releasing hormone neurons, Mol. Endocrinol., 16, 2872, 10.1210/me.2002-0163 · DOI · Paper page
  43. Demirel, 2016, Activity of Corylus avellana seed oil in letrozole-induced polycystic ovary syndrome model in rats, Rev. Bras, 26, 83
  44. Dennett, 2015, The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment, Diabetes Spectrum, 28, 116, 10.2337/diaspect.28.2.116 · DOI · Paper page
  45. Deswal, 2019, Association of luteinizing hormone and LH receptor gene polymorphism with susceptibility of polycystic ovary syndrome, Syst. Biol. Reprod. Med., 65, 400, 10.1080/19396368.2019.1595217 · DOI
  46. Dhaliwal, 2011, Tamoxifen: an alternative to clomiphene in women with polycystic ovary syndrome, J. Hum. Reprod. Sci., 4, 76, 10.4103/0974-1208.86085 · DOI
  47. Di Segni, 2017, Plasmatic and intracellular markers of oxidative stress in normal weight and obese patients with polycystic ovary syndrome, Exp. Clin. Endocrinol. Diabetes, 125, 506, 10.1055/s-0043-111241 · DOI
  48. Docea, 2017, CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides, Toxicol. Rep., 4, 335, 10.1016/j.toxrep.2017.05.007 · DOI
  49. Du, 2010, Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome, Mol. Genet. Metab., 100, 292, 10.1016/j.ymgme.2010.03.018 · DOI
  50. Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis, Endocr. Rev., 18, 774
  51. Dunaif, 1996, The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 81, 3299
  52. Dunn, 2021, Environmental influences and polycystic ovarian syndrome, Clin. Obstet. Gynecol., 64, 33, 10.1097/GRF.0000000000000562 · DOI
  53. Eagleson, 2000, Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone1, J. Clin. Endocrinol. Metab., 85, 4047
  54. Fan, 2005, Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB, Endocrinol, 146, 85, 10.1210/en.2004-1046 · DOI
  55. Fang, 2019, Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway, Phytomed, 64, 10.1016/j.phymed.2019.153074 · DOI
  56. Fatima Farzana, 2015, Effects of flax seeds supplementation in polycystic ovarian syndrome, Int J Pharm Sci Rev Res, 31, 113
  57. Foroozandeh, 2017, Effects of metformin and ginger rhizome extract on the pituitary-gonad function in adult female rats with polycystic ovary syndrome, Armaghane Danesh, 22, 337
  58. Franks, 2008, Follicle dynamics and anovulation in polycystic ovary syndrome, Hum. Reprod. Update, 14, 367, 10.1093/humupd/dmn015 · DOI · Paper page
  59. Gambineri, 2002, Obesity and the polycystic ovary syndrome, Int. J. Obes., 26, 883, 10.1038/sj.ijo.0801994 · DOI · Paper page
  60. George, 2016, Neurokinin b receptor antagonism in women with polycystic ovary syndrome: a randomized, placebo-controlled trial, J. Clin. Endocrinol. Metab., 101, 4313, 10.1210/jc.2016-1202 · DOI · Paper page
  61. Ghafurniyan, 2015, The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat, Iran. J. Pharm. Res., 14, 1215
  62. Ghodke-Puranik, 2013, Valproic acid pathway: pharmacokinetics and pharmacodynamics, Pharmacogenet. Genomics, 23, 236, 10.1097/FPC.0b013e32835ea0b2 · DOI · Paper page
  63. Goswami, 2012, Natural remedies for polycystic ovarian syndrome (PCOS): a review, International journal of pharmaceutical and phytopharmacological research, 1, 396
  64. Gottsch, 2006, Kisspepeptin-gpr54 signaling in the neuroendocrine reproductive axis, Mol. Cell. Endocrinol., 254, 91, 10.1016/j.mce.2006.04.030 · DOI
  65. Grant, 2010, Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial, Phytother. Res., 24, 186, 10.1002/ptr.2900 · DOI · Paper page
  66. Greenwood, 2019, Insulin resistance in polycystic ovary syndrome: concept versus cutoff, Fertil. Steril., 112, 827, 10.1016/j.fertnstert.2019.08.100 · DOI
  67. Herbison, 2001, Lack of detection of estrogen receptor-transcripts in mouse gonadotropin-releasing hormone neurons, Endocrinology, 142, 493
  68. Herzog, 1984, Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovarian syndrome?, Neurology, 34, 1389, 10.1212/WNL.34.10.1389 · doi:10.1212/wnl.34.10.1389
  69. Hrabovszky, 2001, Estrogen receptor-immunoreactivity in luteinizing hormone-releasing hormone neurons of the rat brain, Endocrinology, 142, 3261, 10.1210/endo.142.7.8176 · DOI · Paper page
  70. Hu, 2010, Effects of genistein and equol on human and rat testicular 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase 3 activities, Asian J. Androl., 12, 519, 10.1038/aja.2010.18 · DOI
  71. Huang, 1993, Absence of androgen receptors in lhrh immunoreactive neurons, Brain Res., 624, 309, 10.1016/0006-8993(93)90094-4 · DOI
  72. Huber-Buchholz, 1999, Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone, J. Clin. Endocrinol. Metab., 84, 1470
  73. Ilie, 2015, Polycystic ovary syndrome-epigenetic mechanisms and aberrant microRNA, Adv. Clin. Chem., 71, 25, 10.1016/bs.acc.2015.06.001 · DOI
  74. Jackson, 2000, Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa, Gut, 47, 762, 10.1136/gut.47.6.762 · DOI · Paper page
  75. Jahan, 2016, Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats, J. Ovarian Res., 9, 86, 10.1186/s13048-016-0295-y · DOI
  76. Jahan, 2018, Therapeutic potentials of quercetin in management of polycystic ovarian syndrome using letrozole induced rat model: a histological and a biochemical study, J. Ovarian Res., 11, 1, 10.1186/s13048-018-0400-5 · DOI
  77. Jangam, 2024, Gymnema sylvestre extract improves PCOS by altering the YAP1 protein in the mouse ovary via mitochondrial changes, Phytomedicine Plus, 4, 10.1016/j.phyplu.2023.100515 · DOI
  78. Jin, 2019, Tanshinone IIA attenuates estradiolinduced polycystic ovarian syndrome in mice by ameliorating FSHR expression in the ovary, Exp. Ther. Med., 17, 3501
  79. Joe, 2001, Editorial: polycystic ovarian syndrome—relationship to epilepsy and antiepileptic drug therapy, J. Clin. Endocrinol. Metab., 86, 2946
  80. Jones, 2010, Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study, Health Qual. Life Outcomes, 8, 1, 10.1186/1477-7525-8-149 · DOI
  81. Kakadia, 2019, Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome, J. Tradit. Complement. Med., 9, 336, 10.1016/j.jtcme.2018.03.001 · DOI
  82. Kalra, 2016, The Inositols and polycystic ovary syndrome, Indian J. Endocrinol. Metab., 20, 720, 10.4103/2230-8210.189231 · DOI · Paper page
  83. Kamalanathan, 2013, Pregnancy in polycystic ovary syndrome, Indian Journal of Endocrinology and Metabolism, 17, 37, 10.4103/2230-8210.107830 · DOI
  84. Kamato, 2013, (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells, J. Pharm. Pharmacol., 65, 1026, 10.1111/jphp.12060 · DOI
  85. Karampoor, 2014, The effect of Hydroalcoholic extract of fennel (Foeniculum vulgare) seed on serum levels of sexual hormones in female Wistar rats with polycystic ovarian syndrome (PCOS), J. Arak Univ. Med. Sci., 17, 70
  86. Kargar Jahromi, 2015, The effect of pomegranate juice extract on hormonal changes of female Wistar rats caused by polycystic, Biomed Pharmacol J, 8, 971, 10.13005/bpj/849 · doi:10.13005/bpj/849
  87. Karimi Jashni, 2016, The effect of palm pollen extracts on polycystic ovary syndrome (POS) in rats, Int J Med Res Health Sci, 5, 317
  88. Kauman, 2015, A novel letrozole model recapitulates both the reproductive and metabolic phenotypes of polycystic ovary syndrome in female mice, Biol. Reprod., 93, 69
  89. Kavitha, 2016, Evaluation of effect of Commiphora wightii in dehydroepiandrosterone (DHEA) induced polycystic ovary syndrome (PCOS) in rats, Pharm Tutor, 4, 47
  90. Kazer, 1987, Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 65, 233, 10.1210/jcem-65-2-233 · DOI · Paper page
  91. Kelley, 2019, A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 104, 5299, 10.1210/jc.2019-00383 · DOI
  92. Kim, J.J. and Choi, Y.M., 2013. Dyslipidemia in women with polycystic ovary syndrome. Obstetrics &Gynecology Science, 56(3), pp.137–142. · DOI · Paper page
  93. Kim, 2007, [6]-Gingerol prevents UVB induced ROS production and COX-2 expression in vitro and in vivo, Free Radic. Res., 41, 603, 10.1080/10715760701209896 · DOI · Paper page
  94. Kleemann, 2011, Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models, Atherosclerosis, 218, 44, 10.1016/j.atherosclerosis.2011.04.023 · DOI · Paper page
  95. Komar, 2005, Peroxisome proliferator-activated receptors (PPARs) and ovarian function–implications for regulating steroidogenesis, differentiation, and tissue remodeling, Reprod. Biol. Endocrinol., 3, 1, 10.1186/1477-7827-3-41 · DOI · Paper page
  96. Lai, 2018, Oxidative stress in granulosa cells contributes to poor oocytes quality and IVF-ET outcomes in women with polycystic ovary syndrome, Front. Med., 12, 518, 10.1007/s11684-017-0575-y · DOI · Paper page
  97. Lapatto, 2007, Kiss1/mice exhibit more variable hypogonadism than Gpr54/mice, Endocrinology, 148, 4927, 10.1210/en.2007-0078 · DOI · Paper page
  98. Lee, 2018, Welsh onion root (Allium fistulosum) restores ovarian functions from letrozole induced-polycystic ovary syndrome, Nutrients, 10, 1430, 10.3390/nu10101430 · DOI
  99. Li, 2018, Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome, J. Cell. Physiol., 234, 7435, 10.1002/jcp.27501 · DOI
  100. Li, 2019, Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS), Life Sci., 228, 167, 10.1016/j.lfs.2019.04.046 · DOI · Paper page
  101. Liu, 2021, The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment, Front. Immunol., 12
  102. Liu, 2021, Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality, J. Assist. Reprod. Genet., 38, 471, 10.1007/s10815-020-02014-y · DOI
  103. Lizneva, 2016, Androgen excess: investigations and management, Best Pract. Res. Clin. Obstet. Gynaecol., 37, 98, 10.1016/j.bpobgyn.2016.05.003 · DOI
  104. Lu, 2018, A novel and compact review on the role of oxidative stress in female reproduction, Reprod. Biol. Endocrinol., 16, 1, 10.1186/s12958-018-0391-5 · DOI · Paper page
  105. Lunenfeld, 2019, The development of gonadotropins for clinical use in the treatment of infertility, Front. Endocrinol., 10, 429, 10.3389/fendo.2019.00429 · doi:10.3389/fendo.2019.00429
  106. Luo, 2009, Influence of astragalus polysaccharides plus Diane-35 on insulin resistance and androgen levels and lipid metabolism of patients with polycystic ovary syndrome, Chin. J. Misdiagnost., 2009, 28
  107. Lydic, 2008, Dietary approaches and alternative therapies for polycystic ovary syndrome, Curr. Nutr. Food Sci., 4, 265, 10.2174/157340108786263711 · DOI
  108. Macut, 2017, Insulin and the polycystic ovary syndrome, Diabetes Res. Clin. Pract., 130, 163, 10.1016/j.diabres.2017.06.011 · DOI · Paper page
  109. Maharjan, 2010, Effect of Aloe barbadensis Mill. formulation on letrozole induced polycystic ovarian syndrome rat model, J. Ayurveda Integr. Med., 1, 273, 10.4103/0975-9476.74090 · DOI
  110. Mahood, 2012, Effects of Pimpinella anisum oil extract on some biochemical parameters in mice experimentally induced for human polycystic ovary syndrome, J Biotech Res Centre, 6, 67, 10.24126/jobrc.2012.6.2.228 · DOI
  111. Malekinejad, 2013, Paraquat exposure upregulates cyclooxygenase-2 in the lungs, liver and kidneys in rats, Iran. J. Pharm. Sci., 12, 887
  112. Manasa, 2013, Enzyme-assisted extraction of bioactive compounds from ginger (Zingiber officinale roscoe), Food Chem., 139, 509, 10.1016/j.foodchem.2013.01.099 · DOI · Paper page
  113. Mancini, 2021, Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights, Int. J. Mol. Sci., 22, 1667, 10.3390/ijms22041667 · DOI · Paper page
  114. McDonnell, 2017, Pregnancy-related outcomes for women with polycystic ovary syndrome, Women Health, 13, 89, 10.1177/1745505717731971 · DOI
  115. Messager, 2005, Kisspeptin directly stimulates gonadotropin-releasing hormone release via G-protein-coupled receptor 54, Proc. Natl. Acad. Sci. U. S. A., 102, 1761, 10.1073/pnas.0409330102 · DOI · Paper page
  116. Miao, 2019, Effects of dodder total flavone on polycystic ovary syndrome rat models induced by DHEA combined HCG, Saudi J Biol Sci, 26, 821, 10.1016/j.sjbs.2019.02.007 · DOI
  117. Milić N, Milosević N, Suvajdzić L, Zarkov M, Abenavoli L. New therapeutic potentials of milk thistle (Silybum marianum). Nat. Prod. Commun. 2013;8(12):1801–1810.24555302. · DOI
  118. Mishra, 2021, A case series of invasive mucormycosis in patients with COVID-19 infection, Int. J. Otorhinolaryngol. Head Neck Surg., 7, 867, 10.18203/issn.2454-5929.ijohns20211583 · DOI
  119. Moini Jazani, 2019, A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS), DARU Journal of Pharmaceutical Sciences, 27, 863, 10.1007/s40199-019-00312-0 · DOI
  120. Mombaini, 2017, The impact of green tea supplementation on anthropometric indices and inflammatory cytokines in women with polycystic ovary syndrome, Phytother. Res., 31, 747, 10.1002/ptr.5795 · DOI
  121. Moore, 2017, Polycystic ovary syndrome: understanding the role of the brain, Front. Neuroendocrinol., 46, 1, 10.1016/j.yfrne.2017.05.002 · DOI
  122. Moore, 2013, Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome, Endocrinology, 154, 796, 10.1210/en.2012-1954 · DOI · Paper page
  123. Moore, 2015, Enhancement of a robust arcuate gabaergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome, Proc. Natl. Acad. Sci. U. S. A., 112, 596, 10.1073/pnas.1415038112 · DOI · Paper page
  124. Motamed-Jahromi, 2019, Effect of hydro-alcoholic extract of pumpkin seeds on estrogen hormone and liver markers in adult female rats, KAUMS Journal (FEYZ), 23, 455
  125. Mutharasan, 2013, Evidence for chromosome 2p16. 3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry, J. Clin. Endocrinol. Metab., 98, E185, 10.1210/jc.2012-2471 · DOI · Paper page
  126. Nabiuni, 2015, The effect of curcumin on the estradiol valerate-induced polycystic ovary in rats, Feyz, 18, 515
  127. Najafipour, 2014, Therapeutic effects of stinging nettle (Urtica dioica) in women with hyperandrogenism, Int. J. Curr. Res. Acad. Rev., 2, 153
  128. Ndeingang, 2019, Phyllanthus muellerianus (euphorbiaceae) restores ovarian functions in letrozole-induced polycystic ovarian syndrome in rats, Evid. Based Complement. Alternat. Med., 2019, 2965821, 10.1155/2019/2965821 · DOI
  129. Nowak, 2007, The effect of flaxseed supplementation on hormonal levels associated with polycystic ovarian syndrome: a case study, Curr. Top. Nutraceutical Res., 5, 177
  130. Nugent, 2000, Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome, Cochrane Database Syst. Rev., 2000, 10.1002/14651858.CD000410 · DOI · Paper page
  131. Nugent, 2015, WITHDRAWN: gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome, Cochrane Database Syst. Rev., 24
  132. Nynca, 2013, Effects of the phytoestrogen, genistein, and protein tyrosine kinase inhibitor–dependent mechanisms on steroidogenesis and estrogen receptor expression in porcine granulosa cells of medium follicles, Domest. Anim. Endocrinol., 44, 10, 10.1016/j.domaniend.2012.07.002 · doi:10.1016/j.domaniend.2012.07.002
  133. Osuka, 2016, Kisspeptin in the hypothalamus of 2 rat models of polycystic ovary syndrome, Endocrinology, 158, 367
  134. Özer, 2016, Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome, Ginekol. Pol., 87, 733, 10.5603/GP.2016.0079 · DOI · Paper page
  135. Palioura, 2013, Industrial endocrine disruptors and polycystic ovary syndrome, J. Endocrinol. Investig., 36, 1105, 10.1007/BF03346762 · DOI
  136. Pari, 2007, Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats, Ren. Fail., 29, 881, 10.1080/08860220701540326 · DOI
  137. Parikha, 2019, Anti-hyperglycaemic activity of Tribulus terrestris fruit extract restores metabolic imbalance in letrozole induced- PCOS mice, Int. J. Pharmacogn. Phytochem., 11, 304
  138. Peng, 2022, Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis, Ann. Med., 54, 578, 10.1080/07853890.2022.2034933 · DOI
  139. Petrakis, 2017, Endocrine disruptors leading to obesity and related diseases, Int. J. Environ. Res. Public Health, 14, 1282, 10.3390/ijerph14101282 · DOI · Paper page
  140. Polak, 2017, New markers of insulin resistance in polycystic ovary syndrome, J. Endocrinol. Investig., 40, 1, 10.1007/s40618-016-0523-8 · DOI · Paper page
  141. Poornima, 2015, Evaluation of Pregularia daemia and metformin in the treatment of PCOS in testosterone propionate induced albino Wistar rats (Rattus norvegicus), Int. J. Pharm. Sci. Res., 6, 1250
  142. Qadri, 2018, Polycystic ovary syndrome in bipolar aective disorder: a hospital-based study, Indian J. Psychol. Med., 40, 121, 10.4103/IJPSYM.IJPSYM_284_17 · DOI
  143. Qu, 2012, A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells, J. Mol. Med., 90, 911, 10.1007/s00109-012-0881-4 · DOI
  144. Raheleh, 2022, Effect of catechin on serum levels of inflammatory cytokines, antioxidant enzymes activity and DNA oxidative damage of ovarian tissue in polycystic ovarian syndrome rat model, Pars Journal of Medical Sciences, 15, 23
  145. Rajan, 2017, Soy isoflavones exert beneficial effects on letrozoleinduced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism, Pharm. Biol., 55, 242, 10.1080/13880209.2016.1258425 · DOI · Paper page
  146. Rani, 2022, A landscape analysis of the potential role of polyphenols for the treatment of polycystic ovarian syndrome (PCOS), Phytomedicine Plus, 2, 10.1016/j.phyplu.2021.100161 · DOI
  147. Reddy, 2016, Beneficial effect of curcumin in Letrozole induced polycystic ovary syndrome, Asian Pacific J. Reprod., 5, 116, 10.1016/j.apjr.2016.01.006 · DOI · Paper page
  148. Rice, 2005, Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries, Hum. Reprod., 20, 373, 10.1093/humrep/deh609 · DOI · Paper page
  149. Richards, 2018, Ovarian follicular theca cell recruitment, differentiation, and impact on fertility: 2017 update, Endocr. Rev., 39, 1, 10.1210/er.2017-00164 · DOI · Paper page
  150. Richardson, 2003, Current perspectives in polycystic ovary syndrome, Am. Fam. Physician, 68, 697
  151. Riddell, 2018, Impact of the Affordable Care Act on use of covered contraceptives in women ages 20–25, Popul. Health Manag., 21, 231, 10.1089/pop.2017.0050 · DOI
  152. Roberts, 2020, Current understanding of hypothalamic amenorrhoea, Ther. Adv. Endocrinol. Metab., 11, 10.1177/2042018820945854 · DOI
  153. Rocha, 2013, Quantification of 17 endocrine disrupter compounds and their spatial and seasonal distribution in the Iberian Ave River and its coastline, Toxicol. Environ. Chem., 95, 386, 10.1080/02772248.2013.773002 · DOI
  154. Rothenberg, 2018, Polycystic ovary syndrome in adolescents, Best Pract. Res. Clin. Obstet. Gynaecol., 48, 103, 10.1016/j.bpobgyn.2017.08.008 · DOI
  155. Ruddenklau, 2019, Neuroendocrine impairments of polycystic ovary syndrome, Endocrinology, 160, 2230, 10.1210/en.2019-00428 · DOI · Paper page
  156. Rutkowska, 2016, Polycystic ovary syndrome and environmental toxins, Fertil. Steril., 106, 948, 10.1016/j.fertnstert.2016.08.031 · DOI · Paper page
  157. Sadinpour, 2020, The synergistic effect of Paeonia spp and Glycyrrhiza glabra on polycystic ovary induced in mice, Pak. J. Pharm. Sci., 33
  158. Salmani, 2017, Apigenin’s anticancer properties and molecular mechanisms of action: recent advances and future prospectives, Chin. J. Nat. Med., 15, 321
  159. Sendur, 2021, Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review, Reprod. BioMed. Online, 42, 799, 10.1016/j.rbmo.2020.12.006 · DOI · Paper page
  160. Shakibaei, 2007, Resveratrol inhibits IL-1β–induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro, Ann. N. Y. Acad. Sci., 1095, 554, 10.1196/annals.1397.060 · DOI · Paper page
  161. Silva, 2018, Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS, JCI Insight, 3
  162. Sirotkin, 2020, Puncturevine (Tribulus terrestris L.) affects the proliferation, apoptosis, and ghrelin response of ovarian cells, Reprod. Biol., 20, 33, 10.1016/j.repbio.2019.12.009 · DOI
  163. Smyka, 2017, The role of lifestyle changes in the treatment of polycystic ovary syndrome, Neuroendocrinol. Lett., 38, 521
  164. Soave, 2020, Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion, Curr. Med. Res. Opin., 36, 693, 10.1080/03007995.2020.1729108 · DOI
  165. Sovino, 2002, Clomiphene citrate and ovulation induction, Reprod. BioMed. Online, 4, 303, 10.1016/S1472-6483(10)61821-4 · DOI
  166. Stefanaki, 2018, Chronic stress and body composition disorders: implications for health and disease, Hormones, 17, 33, 10.1007/s42000-018-0023-7 · DOI
  167. Stepto, 2019, Molecular mechanisms of insulin resistance in polycystic ovary syndrome: unraveling the conundrum in skeletal muscle?, J. Clin. Endocrinol. Metab., 104, 5372, 10.1210/jc.2019-00167 · DOI · Paper page
  168. Suhaimi, 2016, Effects of Ficus deltoidea ethanolic leaves extract on female reproductive organs among letrozole-induced polycystic ovarian syndrome rats, J Sci Res Dev, 3, 8
  169. Sullivan, 2004, Prenatal androgens alter gabaergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder, Proc. Natl. Acad. Sci. U. S. A., 101, 7129, 10.1073/pnas.0308058101 · DOI · Paper page
  170. Sun, 2004, In vitro stimulation of granulosa cells by a combination of different active ingredients of Unkei-To, Am. J. Chin. Med., 32, 569, 10.1142/S0192415X0400220X · DOI
  171. Swiglo, 2008, Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and Metaanalyses of randomized controlled trials, J. Clin. Endocrinol. Metab., 93, 1153, 10.1210/jc.2007-2430 · DOI · Paper page
  172. Szczuko, 2017, Significant improvement selected mediators of inflammation in phenotypes of women with PCOS after reduction and low GI diet, Mediat. Inflamm., 2017, 5489523, 10.1155/2017/5489523 · DOI
  173. Szczuko, 2021, Nutrition strategy and life style in polycystic ovary syndrome—narrative review, Nutrients, 13, 2452, 10.3390/nu13072452 · DOI · Paper page
  174. Tahmasebi, 2018, Antioxidant effects of Calligonum extract on ovarian tissue of PCO model: An experimental study, Int J Reprod Biomed, 16, 641
  175. Takahashi, 1994, Effect of TJ-68 (Shakuyaku-kanzo-to) on polycystic ovarian disease, Int. J. Fertil. Menopausal Stud., 39, 69
  176. Tata, 2018, Elevated prenatal anti-müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood, Nat. Med., 24, 834, 10.1038/s41591-018-0035-5 · DOI · Paper page
  177. Ullah, 2017, Protective effects of gaba against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats, J. Ovarian Res., 10, 62, 10.1186/s13048-017-0359-7 · DOI
  178. Umar, 2012, Protective effect of rutin in attenuation of collagen-induced arthritis in Wistar rat by inhibiting inflammation and oxidative stress, Indian J. Rheumatol., 7, 191, 10.1016/j.injr.2012.09.001 · DOI
  179. Unluhizarci, 2009, A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism, J. Endocrinol. Investig., 32, 37, 10.1007/BF03345676 · DOI
  180. Uyanikoglu, 2017, Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study, Biomarkers, 46, 1, 10.1080/1354750X.2016.1265004 · DOI
  181. Viswanathan, 2016, Polycystic ovary syndrome in patients on antiepileptic drugs, Ann. Indian Acad. Neurol., 19, 339, 10.4103/0972-2327.179973 · DOI
  182. Wang, 2020, Cinnamtannin D1 protects pancreatic β-cells from glucolipotoxicity-induced apoptosis by enhancement of autophagy in vitro and in vivo, J. Agric. Food Chem., 68, 12617, 10.1021/acs.jafc.0c04898 · DOI
  183. Wang, 2015, The clinical study on the effect of berberine combined with Cang-Fu-Dao-Tan decoction treating obese women with polycystic ovary syndrome, Guangzhuo Univ Chinese Med
  184. van Westerloo, 2005, Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice, Am. J. Pathol., 166, 721, 10.1016/S0002-9440(10)62293-6 · DOI
  185. Westphal, 2006, Double-blind, placebo-controlled study of fertilityblend: a nutritional supplement for improving fertility in women, Clin. Exp. Obstet. Gynecol., 33, 205
  186. Wüster, 2023, Statin medication improves five-year survival rates in patients with head and neck cancer: a retrospective case-control study of about 100,000 patients, Cancers, 15, 3093, 10.3390/cancers15123093 · DOI
  187. van Wyk BE, Wink M, eds. Medicinal Plants of the World. Portland, OR: Timber Press; 2004:300.
  188. Xita, 2006, Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies, J. Clin. Endocrinol. Metab., 91, 1660, 10.1210/jc.2005-2757 · DOI · Paper page
  189. Yan, 2014, Prenatal androgen excess enhances stimulation of the gnrh pulse in pubertal female rats, J. Endocrinol., 222, 73, 10.1530/JOE-14-0021 · DOI
  190. Yang, 2018, Licorice ethanol extract improves symptoms of polycytic ovary syndrome in letrozole-induced female rats, Integr. Med. Res., 7, 264, 10.1016/j.imr.2018.05.003 · DOI
  191. Yang, 2018, Therapeutic effect of Ecklonia cava extract in letrozole induced polycystic ovary syndrome rats, Front. Pharmacol., 9, 1325, 10.3389/fphar.2018.01325 · DOI
  192. Yarmolinskaya, 2021, The effectiveness of resveratrol in treatment of PCOS on the basis of experimental model in rats, Gynecol. Endocrinol., 37, 54, 10.1080/09513590.2021.2014665 · DOI
  193. Zand Vakili, 2018, The effect of evening primrose oil on changes in polycystic ovary syndrome induced by estradiol valerate in rat, Armaghanedanesh, 22, 714
  194. Zare, 2015, The effects of Urtica dioica extract on lipid profile, insulin resistance index and liver histology in polycystic ovary syndrome-induced Wistar rats, Adv. Herb. Med., 1, 23
  195. Zeng, 2022, Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies, Front. Pharmacol., 13, 10.3389/fphar.2022.874914 · DOI
  196. Zhang, 2020, HMGB1-induced aberrant autophagy contributes to insulin resistance in granulose cells in PCOS, FASEB J., 34, 9563, 10.1096/fj.202000605RR · DOI · Paper page
  197. Zhang, 2017, Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome, Clin. Endocrinol., 86, 88, 10.1111/cen.13171 · DOI
  198. Zhao, 2013, Ethnic differences in the phenotypic expression of polycystic ovary syndrome, Steroids, 78, 755, 10.1016/j.steroids.2013.04.006 · DOI
  199. Zhu, 2019, Sex hormone-binding globulin and polycystic ovary syndrome, Clin. Chim. Acta, 499, 142, 10.1016/j.cca.2019.09.010 · DOI · Paper page
  200. Zong, 2022, Effects of gonadotropin-releasing hormone analogs on ovarian function against chemotherapy-induced gonadotoxic effects in premenopausal women with breast cancer in China: a randomized clinical trial, JAMA Oncol., 8, 252, 10.1001/jamaoncol.2021.6214 · DOI

Cited by

See all 65

Metadata

Authors
Hajam, Y. A., Rather, H. A., Neelam, Kumar, R., Basheer, M., & Reshi, M. S.
Venue
Endocrine and Metabolic Science
Publisher
Elsevier BV
Published
2024-03
Volume
14
Pages
100162
ISSN
2666-3961 (ISSN-L)
OpenAlex
W4391365482
Cited by
65
References
49
FWCI
21.08
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A review on critical appraisal and pathogenesis of polycystic ovarian syndrome. https://app.cochat.ai/papers/10.1016/j.endmts.2024.100162
The paper
Hajam, Y. A., Rather, H. A., Neelam, Kumar, R., Basheer, M., & Reshi, M. S. (2024). A review on critical appraisal and pathogenesis of polycystic ovarian syndrome. Endocrine and Metabolic Science. https://doi.org/10.1016/j.endmts.2024.100162

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.